Stryker

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Stryker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. 

CEO
Kevin A. Lobo
CEOKevin A. Lobo
Employees
53,000
Employees53,000
Headquarters
Portage, Michigan
HeadquartersPortage, Michigan
Founded
1941
Founded1941
Employees
53,000
Employees53,000

SYK Key Statistics

Market cap
137.88B
Market cap137.88B
Price-Earnings ratio
46.72
Price-Earnings ratio46.72
Dividend yield
0.96%
Dividend yield0.96%
Average volume
1.89M
Average volume1.89M
High today
$361.42
High today$361.42
Low today
$356.65
Low today$356.65
Open price
$358.73
Open price$358.73
Volume
592.17K
Volume592.17K
52 Week high
$406.19
52 Week high$406.19
52 Week low
$329.16
52 Week low$329.16

Stock Snapshot

As of today, Stryker(SYK) shares are valued at $360.53. The company's market cap stands at 137.88B, with a P/E ratio of 46.72 and a dividend yield of 95.6%.

During the trading session on 2026-01-15, Stryker(SYK) shares reached a daily high of $361.42 and a low of $356.65. At a current price of $360.53, the stock is +1.1% higher than the low and still -0.2% under the high.

Trading volume for Stryker(SYK) stock has reached 592.17K, versus its average volume of 1.89M.

The stock's 52-week range extends from a low of $329.16 to a high of $406.19.

The stock's 52-week range extends from a low of $329.16 to a high of $406.19.

SYK News

TipRanks 6d
Stryker price target raised to $465 from $450 at Bernstein

Bernstein analyst Lee Hambright raised the firm’s price target on Stryker (SYK) to $465 from $450 and keeps an Outperform rating on the shares. After a low poin...

Simply Wall St 7d
A Look At Stryker Valuation After Raymond James Outperform Upgrade

Raymond James’ upgrade of Stryker (SYK) to “Outperform” has put the stock back in focus after the firm highlighted five years of double digit organic revenue gr...

A Look At Stryker Valuation After Raymond James Outperform Upgrade

Analyst ratings

81%

of 32 ratings
Buy
81.3%
Hold
15.6%
Sell
3.1%

People also own

Based on the portfolios of people who own SYK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .